On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
URAL INSTRUMENT-ENGINEERING PLANT JSC (UIMP JSC, part of Concern Radio-cum-Electronic Technologies JSC (KRET) of the Rostec State Corporation) is a manufacturer of competitive medical equipment and a participant in state programs for the development of the radio-electronic industry. The company has a research and development center (R&D center), which is involved in the implementation of promising research, development and technology, market analysis and development of innovative solutions in the field of medical device industry.
Description of medical products:
Artificial lung ventilation device Mobivent

A high-end turbine-driven device for stationary use, as well as for patient transportation, within professional healthcare facilities.
Equipped with a display with adjustable tilt angle, graphical interface, advanced element base and a wide range of ventilation modes, special functions and additional options. Designed for patients weighing from 2 to 300 kg.
Artificial lung ventilation device Mobivent OKSI
A compact solution for high-flow oxygen therapy in adult and pediatric patients, with a built-in humidification system for intensive care of independently breathing adults and children, in inpatient treatment for conditions requiring an intensive flow of heated and humidified breathing oxygen-air mixture.
Transport artificial lung ventilation device Mobivent ARM
A device for transporting patients (adults and children, weighing from 2 to 300 kg) by ambulances, aircraft, inside healthcare facilities, as well as in operating rooms and intensive care units.
Compact size 6.5 kg, 8-inch color touch display, high turbine performance and autonomous operation up to 10 hours.
Central Monitoring Station (CMS)
A modern digital system for centralized monitoring, collection and processing of patient's vital parameters data from bedside medical equipment by a wide range of manufacturers and of various types:
Artificial lung ventilation devices
Anesthesia and respiratory devices
Patient monitors
Syringe and volumetric pumps
Contacts of the enterprise – 25 km of the Chelyabinsk Tract, Sysert District, Sverdlovsk Region, 624005. Tel: 8 (800) 222-58-40, e- mail: mail@upz.ru, www.upz.ru.